Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial

Maxime Dougados; Anne Le Henanff; Isabelle Logeart; Philippe Ravaud

doi:10.1371/journal.pctr.0020009

Loading metrics

Open Access

Peer-reviewed

Research Article

Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial

Maxime Dougados ,

*To whom correspondence should be addressed. E-mail: maxime.dougados@cch.aphp.fr

Affiliations Faculté de Médecine, Université Paris-Descartes, Paris, France, Service de Rheumatologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France
⨯
Anne Le Henanff,

Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM) E0357, Faculté Xavier Bichat (Université Paris 7), Paris, France, Département d'Epidémiologie, Biostatistique et Recherche Clinique, Groupe Hospitalier Bichat-Claude Bernard (Assistance Publique–Hôpitaux de Paris), Paris, France
⨯
Isabelle Logeart,

Affiliation Merck, Sharp and Dohme Chibret Laboratories, Paris, France
⨯
Philippe Ravaud

Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM) E0357, Faculté Xavier Bichat (Université Paris 7), Paris, France, Département d'Epidémiologie, Biostatistique et Recherche Clinique, Groupe Hospitalier Bichat-Claude Bernard (Assistance Publique–Hôpitaux de Paris), Paris, France
⨯

Short-Term Efficacy of Rofecoxib and Diclofenac in Acute Shoulder Pain: A Placebo-Controlled Randomized Trial

Maxime Dougados,
Anne Le Henanff,
Isabelle Logeart,
Philippe Ravaud

Published: March 9, 2007
https://doi.org/10.1371/journal.pctr.0020009

About the Authors

Maxime Dougados

*To whom correspondence should be addressed. E-mail: maxime.dougados@cch.aphp.fr

Affiliations Faculté de Médecine, Université Paris-Descartes, Paris, France, Service de Rheumatologie, Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Paris, France

Anne Le Henanff

Affiliations Institut National de la Santé et de la Recherche Médicale (INSERM) E0357, Faculté Xavier Bichat (Université Paris 7), Paris, France, Département d'Epidémiologie, Biostatistique et Recherche Clinique, Groupe Hospitalier Bichat-Claude Bernard (Assistance Publique–Hôpitaux de Paris), Paris, France

Isabelle Logeart

Affiliation Merck, Sharp and Dohme Chibret Laboratories, Paris, France

Philippe Ravaud

Competing Interests

The first author's department has received grants from MSD in order to conduct studies in the field of rheumatology, and this author has also acted as a member of an advisory board for MSD. IL is an associate medical director of Merck France.

Author Contributions

MD and IL designed the study and wrote the paper. MD, ALH, and PR analyzed the data. MD enrolled patients.

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Pain
Is the Subject Area "Pain" applicable to this article?

Thanks for your feedback.
NSAIDs
Is the Subject Area "NSAIDs" applicable to this article?

Thanks for your feedback.
Shoulders
Is the Subject Area "Shoulders" applicable to this article?

Thanks for your feedback.
Steroids
Is the Subject Area "Steroids" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Steroid therapy
Is the Subject Area "Steroid therapy" applicable to this article?

Thanks for your feedback.
COX-2 inhibitors
Is the Subject Area "COX-2 inhibitors" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.